Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02751
Species: Homo sapiens
Position : chr10:51546800-51547317
Year: 2016
Title: Chromatin interactions and candidate genes at ten prostate cancer risk loci.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  26979803
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: LNCaP
CVCL ID: CVCL_0395
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Chromatin interaction assay, TF binding assay; Chromatin interaction assay; Disease-variant functional analysis
High Throughput Method: Capture 3C-seq, ChIP-seq, RNA-seq, SNP genotyping array; eQTL analysis; GWAS
Low Throughput Method: Luciferase reporter assay, Site-directed mutagenesis, 3C-qPCR, RT-qPCR; 3C
About Target Gene
Target gene : ANTXRLP1
About TF
TF name : HOXB13
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
HOXB13 Regulation of Androgen receptor activity pid 54
Enhancer Associated Network
Overlapping Enhancers (hg19) 15 found
Enhancer ID Position Tissue Cell Disease
E_02744 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02745 chr10:51546800-51547317 prostate gland malignant cell prostate cancer
E_02746 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02747 chr10:51546800-51547317 prostate gland malignant cell prostate cancer
E_02748 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02749 chr10:51546800-51547317 prostate gland malignant cell prostate cancer
E_02750 chr10:51546800-51547317 uterine cervix malignant cell cervical cancer
E_02800 chr10:51546800-51547317 prostate gland NA prostate cancer
E_02801 chr10:51546800-51547317 prostate gland NA prostate cancer
E_02802 chr10:51546800-51547317 prostate gland NA prostate cancer
E_02803 chr10:51546800-51547317 prostate gland NA prostate cancer
E_02821 chr10:51546800-51547317 prostate gland NA NA
E_02822 chr10:51546800-51547317 prostate gland NA NA
E_02823 chr10:51546800-51547317 prostate gland NA NA
E_02824 chr10:51546800-51547317 prostate gland NA NA
Expression of Target Genes for the Enhancer